c-Ha-Ras mutants with point mutations in Gln-Val-Val region have reduced inhibitory activity toward cathepsin B
- 1 May 1993
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 69 (3) , 161-165
- https://doi.org/10.1016/0304-3835(93)90169-a
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Identification of amino acid residues of Ras protein that are essential for signal-transducing activity but not for enhancement of GTPase activity by GAPFEBS Letters, 1991
- The biochemistry of ras p21Biochemical Journal, 1991
- The ras protein family: evolutionary tree and role of conserved amino acidsBiochemistry, 1991
- Evolution of proteins of the cystatin superfamilyJournal of Molecular Evolution, 1990
- Cysteine proteinase inhibitors and rasgene products share the same biological activities including tranforming activity toward NIH3T3 mouse fibroblasts and the differentiation-inclucing activity toward PC12 rat pheochromocytoma cellsCarcinogenesis: Integrative Cancer Research, 1990
- Inhibition of cathepsin L-induced degradation of epidermal growth factor receptors by c-Ha-ras gene productsBiochemical and Biophysical Research Communications, 1988
- Degradation of a cAMP-binding protein is inhibited by human c-Ha-ras gene productsBiochemical and Biophysical Research Communications, 1987
- c‐Ha‐ras gene products are potent inhibitors of cathepsins B and LFEBS Letters, 1987
- Activation of ras p21 transforming properties associated with an increase in the release rate of bound guanine nucleotide.Molecular and Cellular Biology, 1986
- Mutational analysis of a ras catalytic domain.Molecular and Cellular Biology, 1986